PMA P170043S012

Device
iStent inject® Trabecular Micro-Bypass System Model
Applicant
Glaukos Corporation
PMA number
P170043
Supplement
S012
Product code
OGO
Decision date
2022-02-18
Generic name
Intraocular pressure lowering implant
Approval order statement
Change to the sampling plan for Limulus Amebocyte Lysate (LAL) endotoxin testing.

Current openFDA PMA Record#

Device
iStent inject® Trabecular Micro-Bypass System Model
Applicant
Glaukos Corporation
PMA number
P170043
Supplement
S012
Product code
OGO
Generic name
Intraocular pressure lowering implant
Decision date
2022-02-18
Decision code
OK30
Date received
2022-02-04
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
Change to the sampling plan for Limulus Amebocyte Lysate (LAL) endotoxin testing.